Delivery Order SPE2DB24D1006-SPE2DB25FCFBM
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for OJJAARA 100 mg tablets in quantities of 30, with a contract ceiling value of $17,912.32. This firm fixed-price delivery order, set to be completed by August 14, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in quantities of 30s, with a ceiling value of $35,699.72 under a firm fixed-price contract type. The delivery order, issued on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive procurement action. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,912.32 by the Defense Logistics Agency's Medical Supply Chain to supply OJJAARA 100 mg tablets in packages of 30 units. This firm fixed-price contract, awarded on August 28, 2025, with a completion date of September 19, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's...
- The Defense Logistics Agency has awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of OJJAARA 150 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $17,863.71, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total ceiling value of $999,999,999.00 through December 2026. The contract contains no set-aside...
- This is a $17,849.85 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through July 28, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ojjaara 200 mg tablets in packages of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $17,849.85 with firm fixed pricing and is scheduled for completion by September 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same municipality....
- This is a $17,165.69 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of OJJAARA 200 MG TABLET medication and has a period of performance through July 1, 2024. Amerisourcebergen, a leading pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568062474 OJJAARA 200 MG TABLET UU 30S, with a ceiling value of $17,849.85. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract, valued at up to $17,093.49, awarded to AmerisourceBergen Drug Corporation's Corporate Office division. The award is for the supply of 4565405842 ! OJJAARA 100 MG TABLET UU 30S, a pharmaceutical product. The delivery order has a firm fixed price pricing type and an ultimate completion date of August 30, 2024. There is no set-aside designation for this award. As one of the...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCFBMDelivery Order
The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units, with a completion date of September 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order represents a routine transaction within the company's broader role as a prime pharmaceutical vendor for the Department of Defense's global medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 9/2/25 |